Dr Sonali Gnanenthiran, from the ANZAC Research Institute’s Vascular Biology Group, has been awarded the 2023 Karl Link Early Career Investigator Award in Thrombosis from the American Heart Association.

The Karl Link Early Career Investigator Award in Thrombosis is given to the most outstanding paper published in the Thrombosis section of the journal Arteriosclerosis, Thrombosis, and Vascular Biology during the previous year. The award is named after Dr Karl Link, an investigator who discovered warfarin, a widely used anticoagulant drug.

Dr Gnanenthiran’s paper, Identification of a Distinct Platelet Phenotype in the Elderly: ADP Hypersensitivity co-exists with Thrombin Resistance, was selected from a pool of over 320 submissions.

Dr Gnanenthiran’s research focuses on the role of platelets in thrombosis, a condition in which blood clots abnormally. Her work has the potential to lead to new treatments for thrombosis, which is a major cause of heart attack, stroke, and other cardiovascular diseases.

Congratulations to Dr Sonali Gnanenthiran on this prestigious award!